168 related articles for article (PubMed ID: 16741312)
1. 18F-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: a validation study.
Iozzo P; Gastaldelli A; Järvisalo MJ; Kiss J; Borra R; Buzzigoli E; Viljanen A; Naum G; Viljanen T; Oikonen V; Knuuti J; Savunen T; Salvadori PA; Ferrannini E; Nuutila P
J Nucl Med; 2006 Jun; 47(6):1016-22. PubMed ID: 16741312
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 1-(11)C-glucose and (18)F-FDG for quantifying myocardial glucose use with PET.
Herrero P; Sharp TL; Dence C; Haraden BM; Gropler RJ
J Nucl Med; 2002 Nov; 43(11):1530-41. PubMed ID: 12411556
[TBL] [Abstract][Full Text] [Related]
3. Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET Study.
Iozzo P; Geisler F; Oikonen V; Mäki M; Takala T; Solin O; Ferrannini E; Knuuti J; Nuutila P;
J Nucl Med; 2003 May; 44(5):682-9. PubMed ID: 12732668
[TBL] [Abstract][Full Text] [Related]
4. Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs.
Iozzo P; Jarvisalo MJ; Kiss J; Borra R; Naum GA; Viljanen A; Viljanen T; Gastaldelli A; Buzzigoli E; Guiducci L; Barsotti E; Savunen T; Knuuti J; Haaparanta-Solin M; Ferrannini E; Nuutila P
Gastroenterology; 2007 Feb; 132(2):531-42. PubMed ID: 17258736
[TBL] [Abstract][Full Text] [Related]
5. Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT.
Hovorka R; Shojaee-Moradie F; Carroll PV; Chassin LJ; Gowrie IJ; Jackson NC; Tudor RS; Umpleby AM; Jones RH
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E992-1007. PubMed ID: 11934663
[TBL] [Abstract][Full Text] [Related]
6. Metabolic handling of orally administered glucose in cirrhosis.
Kruszynska YT; Meyer-Alber A; Darakhshan F; Home PD; McIntyre N
J Clin Invest; 1993 Mar; 91(3):1057-66. PubMed ID: 8450036
[TBL] [Abstract][Full Text] [Related]
7. Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range.
Jani R; Molina M; Matsuda M; Balas B; Chavez A; DeFronzo RA; Abdul-Ghani M
Diabetes Care; 2008 Feb; 31(2):311-5. PubMed ID: 18000182
[TBL] [Abstract][Full Text] [Related]
8. Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
Trägårdh M; Møller N; Sørensen M
J Nucl Med; 2015 Sep; 56(9):1366-71. PubMed ID: 26159590
[TBL] [Abstract][Full Text] [Related]
9. Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia.
Zangeneh F; Basu R; Shah P; Arora P; Camilleri M; Rizza RA
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E280-6. PubMed ID: 12857674
[TBL] [Abstract][Full Text] [Related]
10. Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes.
Basu R; Schwenk WF; Rizza RA
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E55-62. PubMed ID: 14982753
[TBL] [Abstract][Full Text] [Related]
11. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin.
Jazet IM; Pijl H; Frölich M; Romijn JA; Meinders AE
Metabolism; 2005 Jun; 54(6):705-12. PubMed ID: 15931603
[TBL] [Abstract][Full Text] [Related]
12. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
Tietge UJ; Selberg O; Kreter A; Bahr MJ; Pirlich M; Burchert W; Müller MJ; Manns MP; Böker KH
Liver Transpl; 2004 Aug; 10(8):1030-40. PubMed ID: 15390330
[TBL] [Abstract][Full Text] [Related]
13. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
[TBL] [Abstract][Full Text] [Related]
14. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
15. Glucose production, oxidation and disposal correlate with plasma lactate levels in HIV-infected patients on HAART.
Haugaard SB; Andersen O; Madsbad S; Iversen J; Dela F
J Infect; 2007 Jan; 54(1):89-97. PubMed ID: 16487595
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of wortmannin on insulin's hemodynamic and metabolic actions in vivo.
Bradley EA; Clark MG; Rattigan S
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E779-87. PubMed ID: 17106063
[TBL] [Abstract][Full Text] [Related]
17. Assessment of postprandial glucose metabolism: conventional dual- vs. triple-tracer method.
Toffolo G; Basu R; Dalla Man C; Rizza R; Cobelli C
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E800-6. PubMed ID: 16720627
[TBL] [Abstract][Full Text] [Related]
18. Effects of anesthetic agents and fasting duration on 18F-FDG biodistribution and insulin levels in tumor-bearing mice.
Lee KH; Ko BH; Paik JY; Jung KH; Choe YS; Choi Y; Kim BT
J Nucl Med; 2005 Sep; 46(9):1531-6. PubMed ID: 16157537
[TBL] [Abstract][Full Text] [Related]
19. Metabolic characteristics of soleus muscle in relation to insulin action in the offspring of hypertensive parents.
Kratochvílová S; Vyhnanovská P; Vlasáková Z; Hájek M; Skibová J; Pelikánová T
Metabolism; 2006 Oct; 55(10):1388-96. PubMed ID: 16979411
[TBL] [Abstract][Full Text] [Related]
20. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
